Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington

(2021) Maria A. Corcorran et al.   DRUG AND ALCOHOL DEPENDENCE

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)

(2021) Lars T. Fadnes et al.   PLOS MEDICINE

Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials

(2021) Jan Klimas et al.   Systematic Reviews

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

(2020) Elana S Rosenthal et al.   CLINICAL INFECTIOUS DISEASES

Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases ― United States, 2009–2018

(2020) A. Blythe Ryerson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy

(2019) Matthew J. Akiyama et al.   ANNALS OF INTERNAL MEDICINE

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

(2019) Evan B Cunningham et al.   CLINICAL INFECTIOUS DISEASES

Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study

(2019) Alain H. Litwin et al.   Contemporary Clinical Trials

Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

(2018) Megan G. Hofmeister et al.   HEPATOLOGY

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

(2017) Louisa Degenhardt et al.   Lancet Global Health

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

(2015) Soumitri Barua et al.   ANNALS OF INTERNAL MEDICINE

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

(2013) Yih-Ing Hser et al.   ADDICTION